Henan Lingrui Pharmaceutical Co (SHSE:600285) Moat Score: 0/10 (As of Jul. 13, 2026)


SHSE:600285 Henan Lingrui Pharmaceutical Co Ltd SHSE:600285
97 GF Score
Price ¥22.66
GF Value ¥24.39
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Henan Lingrui Pharmaceutical Co Moat Score?

Henan Lingrui Pharmaceutical Co has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Henan Lingrui Pharmaceutical Co has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Henan Lingrui Pharmaceutical Co might have No Moat - No discernible moat.

Henan Lingrui Pharmaceutical Co  (SHSE:600285) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Henan Lingrui Pharmaceutical Co Moat Score Related Terms

SHSE:600285
97GF Score
Henan Lingrui Pharmaceutical Co Ltd SHSE:600285
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Henan Lingrui Pharmaceutical Co (SHSE:600285) Overvalued in 2026?

Based on GuruFocus' analysis, Henan Lingrui Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥22.66 is trading 7.1% below its estimated GF Value™ of ¥24.39. GuruFocus considers Henan Lingrui Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SHSE:600285:

  • Moat Score: 0
  • GF Value™: ¥24.39 vs. price of ¥22.66 (7.1% below fair value)
  • GF Score™: 97/100 with 2 warning signs

No single metric tells the full story. See the SHSE:600285 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Henan Lingrui Pharmaceutical Co Business Description

Address No. 59 Jiefang Chengguan Road, Xinxian, Xinyang, Henan, CHN, 465550
Henan Lingrui Pharmaceutical Co Ltd is a Chinese company engaged in the development, production, and distribution of pharmaceuticals. The Company's products include tablets, capsules, injections and other medicines.
97GF Score

Get the complete analysis for SHSE:600285

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥22.66
Price
¥24.39
GF Value